The modern approach to cardiac care is increasingly centered on continuous observation, earlier intervention, and connected patient management. This shift is reshaping the global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, which was valued at USD 30.0 billion in 2025 and is projected to reach USD 49.8 billion by 2033, expanding at a CAGR of 6.5% from 2026 to 2033.

The market is being influenced by the rising prevalence of cardiovascular diseases and arrhythmias, an expanding aging population, and lifestyle-related risk factors. At the same time, cardiac care is becoming increasingly connected, with wearable ECG devices, implantable monitors, remote monitoring platforms, and technologically advanced rhythm-management systems extending care beyond traditional hospital environments.

The Market Is Becoming More Continuous

Traditional cardiac evaluation often depended on examinations performed at specific points in time. The increasing adoption of wearable and remote technologies is changing that model.

Patients can now be monitored through wearable ECG systems, implantable loop recorders, mobile cardiac telemetry, and connected platforms. These technologies can collect cardiac information outside hospitals and transmit it through secure connectivity channels for clinical review.

This transition is particularly important for conditions in which abnormalities may not occur during a short clinical examination. Continuous or extended monitoring can provide clinicians with a broader picture of cardiac activity and support earlier identification of rhythm abnormalities.

A Market Where Rhythm Management Still Holds the Lead

Cardiac rhythm management devices accounted for 73.6% of the market in 2025, making them the dominant product category. Pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy systems remain essential for managing conditions such as bradycardia, tachycardia, heart failure, and other rhythm disorders.

Download a free sample report or claim your copy of this full market intelligence report

Innovation is increasingly focused on making these devices smaller, longer-lasting, more connected, and compatible with modern clinical workflows.

In March 2025, MicroPort Scientific Corporation launched its TEN pacemaker family in China. The series includes compact, long-life models with AutoMRI compatibility and functionality for sleep and arrhythmia monitoring. Such developments demonstrate how device engineering is moving toward more sophisticated long-term cardiac management.

Monitoring Is the Faster-Moving Opportunity

Although rhythm management currently dominates, cardiac monitoring devices are expected to register the fastest CAGR through 2033.

Holter monitors, event recorders, mobile cardiac telemetry systems, and ECG devices are increasingly being integrated with smartphones, cloud platforms, and remote clinical workflows. In April 2025, LifeSignals introduced the UbiqVue 2AYe Holter System, using a disposable chest-worn biosensor capable of continuously recording two-channel ECG and event data for up to five days.

The system transmits information through a mobile application to a cloud platform, where ECG data can be analyzed and made available to physicians more rapidly.

Hospitals Still Lead, but Care Is Moving Outward

Hospitals accounted for 53.4% of market revenue, reflecting their central role in managing high-acuity patients and performing device-based interventions.

Yet the boundaries of cardiac care are expanding. Ambulatory surgery centers are increasingly involved in procedures such as pacemaker and loop recorder implantation, while remote monitoring platforms allow patients to remain connected to clinical teams after discharge.

North America Leads; Asia Pacific Builds Momentum

North America held the largest regional share at 45.6% in 2025. The region benefits from advanced healthcare infrastructure, high adoption of innovative cardiac technologies, and a substantial burden of cardiovascular conditions.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

The U.S. remains particularly important. The increasing prevalence of atrial fibrillation is supporting demand for both monitoring and rhythm-management technologies, while new product clearances continue to expand the range of available solutions.

Asia Pacific presents a different growth story. The region is expected to record the fastest CAGR through 2033, supported in part by its rapidly aging population and rising cardiovascular disease burden. Around 697 million people aged 60 years or older lived in Asia and the Pacific in 2023, creating a substantial population base requiring cardiovascular monitoring and management.

China also represents a significant opportunity, with a large cardiovascular disease burden driving demand for advanced diagnostic and therapeutic technologies.

Explore Our Research & Intelligence Solutions

Prism AI: Ask. Analyze. Get Cited Market Insights. – Explore Now

U.S. Healthcare Facility Intelligence: Make Better Decisions with Comprehensive Data – Explore the Platform